208
Views
0
CrossRef citations to date
0
Altmetric
Review

Exploring the complex relationship between the lung microbiome and ventilator-associated pneumonia

, ORCID Icon, , , & ORCID Icon
Pages 889-901 | Received 14 Jun 2023, Accepted 17 Oct 2023, Published online: 27 Oct 2023

References

  • Lira-Lucio JA, Falfan-Valencia R, Ramirez-Venegas A, et al. Lung microbiome participation in Local immune response Regulation in respiratory diseases. Microorganisms. [2020 Jul 16];8(7):1059. doi: 10.3390/microorganisms8071059
  • Moffatt MF, Cookson WO. The lung microbiome in health and disease. Clin Med. 2017 Dec;17(6):525–529. doi: 10.7861/clinmedicine.17-6-525
  • Unger SA, Bogaert D. The respiratory microbiome and respiratory infections. J Infect. 2017 Jun;74(Suppl 1):S84–S88. doi: 10.1016/S0163-4453(17)30196-2
  • Invernizzi R, Lloyd CM, Molyneaux PL. Respiratory microbiome and epithelial interactions shape immunity in the lungs. Immunology. 2020 Jun;160(2):171–182. doi: 10.1111/imm.13195
  • Yang D, Xing Y, Song X, et al. The impact of lung microbiota dysbiosis on inflammation. Immunology. 2020 Feb;159(2):156–166. doi: 10.1111/imm.13139
  • Yagi K, Huffnagle GB, Lukacs NW, et al. The lung microbiome during health and disease. Int J Mol Sci. [2021 Oct 8];22(19):10872. doi: 10.3390/ijms221910872
  • Wang J, Li F, Tian Z. Role of microbiota on lung homeostasis and diseases. Sci China Life Sci. 2017 Dec;60(12):1407–1415. doi: 10.1007/s11427-017-9151-1
  • Mandell LA, Wunderink RG, Anzueto A, et al. Infectious diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. [2007 Mar 1];44(Suppl 2):S27–72. doi: 10.1086/511159
  • Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults N Engl J Med. [2015 Jul 30];373(5):415–427. doi: 10.1056/NEJMoa1500245
  • Torres A, Cilloniz C, Niederman MS, et al. Pneumonia. Nat Rev Dis Primers. [2021 Apr 8];7(1):25. doi: 10.1038/s41572-021-00259-0
  • Torres A, Niederman MS, Chastre J, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (Hap)/ventilator-associated pneumonia (VAP) of the European respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of clinical Microbiology and Infectious diseases (ESCMID) and asociacion latinoamericana del torax (ALAT). Eur Respir J. 2017 Sep;50(3):1–26.
  • American Thoracic S, Infectious Diseases Society of A. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. [2005 Feb 15];171(4):388–416. doi: 10.1164/rccm.200405-644ST
  • Wu BG, Segal LN. The lung microbiome and its role in pneumonia. Clin Chest Med. 2018 Dec;39(4):677–689. doi: 10.1016/j.ccm.2018.07.003
  • Bos LDJ, Kalil AC. Changes in lung microbiome do not explain the development of ventilator-associated pneumonia. Intensive care Med. 2019 Aug;45(8):1133–1135. doi: 10.1007/s00134-019-05691-1
  • Fastres A, Felice F, Roels E, et al. The lung microbiome in idiopathic pulmonary fibrosis: a promising approach for targeted therapies. Int J Mol Sci. [2017 Dec 16];18(12):2735. doi: 10.3390/ijms18122735
  • Araghi A. The lung microbiome and pneumonia: where precision medicine meets pulmonology. Pulmonology. 2020 Nov;26(6):333–334. doi: 10.1016/j.pulmoe.2020.04.005
  • Andrejak C, Delhaes L. The lung microbiome in 2015: a window on chronic lung diseases. Med Sci (Paris). 2015 Nov;31(11):971–978. doi: 10.1051/medsci/20153111011
  • Beck JM, Young VB, Huffnagle GB. The microbiome of the lung. Transl Res. 2012 Oct;160(4):258–266. doi: 10.1016/j.trsl.2012.02.005
  • Budden KF, Shukla SD, Rehman SF, et al. Functional effects of the microbiota in chronic respiratory disease. Lancet Respir Med. 2019 Oct;7(10):907–920. doi: 10.1016/S2213-2600(18)30510-1
  • Whiteside SA, McGinniss JE, Collman RG. The lung microbiome: progress and promise. J Clin Invest. [2021 Aug 2];131(15). doi: 10.1172/JCI150473
  • Pettigrew MM, Tanner W, Harris AD. The lung microbiome and pneumonia. J Infect Dis. [2021 Jun 16];223(12 Suppl 2):S241–S245. doi: 10.1093/infdis/jiaa702
  • Alcon A, Fabregas N, Torres A. Pathophysiology of pneumonia. Clin Chest Med. 2005 Mar;26(1):39–46. doi: 10.1016/j.ccm.2004.10.013
  • Fernandez-Barat L, Lopez-Aladid R, Torres A. Reconsidering ventilator-associated pneumonia from a new dimension of the lung microbiome. EBioMedicine. 2020 Oct;60:102995. doi: 10.1016/j.ebiom.2020.102995
  • Dickson RP, Erb-Downward JR, Huffnagle GB. Homeostasis and its disruption in the lung microbiome. Am J Physiol Lung Cell Mol Physiol. [2015 Nov 15];309(10):L1047–55. doi: 10.1152/ajplung.00279.2015
  • Fenn D, Abdel-Aziz MI, van Oort PMP, et al. Composition and diversity analysis of the lung microbiome in patients with suspected ventilator-associated pneumonia. Crit Care. [2022 Jul 6];26(1):203. doi: 10.1186/s13054-022-04068-z
  • Martin-Loeches I, Dickson R, Torres A, et al. The importance of airway and lung microbiome in the critically ill. Crit Care. [2020 Aug 31];24(1):537. doi: 10.1186/s13054-020-03219-4
  • Perez-Cobas AE, Baquero F, de Pablo R, et al. Altered ecology of the respiratory tract microbiome and nosocomial pneumonia. Front Microbiol. 2021;12:709421. doi: 10.3389/fmicb.2021.709421
  • Papazian L, Klompas M, Luyt CE. Ventilator-associated pneumonia in adults: a narrative review. Intensive care Med. 2020 May;46(5):888–906. doi: 10.1007/s00134-020-05980-0
  • Bonten MJ, Kollef MH, Hall JB. Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. Clin Infect Dis. [2004 Apr 15];38(8):1141–1149. doi: 10.1086/383039
  • Bonell A, Azarrafiy R, Huong VTL, et al. A systematic review and meta-analysis of ventilator-associated pneumonia in adults in Asia: An analysis of national income level on incidence and etiology. Clin Infect Dis. [2019 Jan 18];68(3):511–518. doi: 10.1093/cid/ciy543
  • Clancy CJ, Kalil AC, Fowler VG, et al. Emerging and resistant infections. Ann Am Thorac Soc. 2014 Aug;11(Suppl 4):S193–200. doi: 10.1513/AnnalsATS.201402-069PL
  • Emonet S, Lazarevic V, Leemann Refondini C, et al. Identification of respiratory microbiota markers in ventilator-associated pneumonia. Intensive care Med. 2019 Aug;45(8):1082–1092. doi: 10.1007/s00134-019-05660-8
  • Fernando SM, Tran A, Cheng W, et al. Diagnosis of ventilator-associated pneumonia in critically ill adult patients-a systematic review and meta-analysis. Intensive care Med. 2020 Jun;46(6):1170–1179. doi: 10.1007/s00134-020-06036-z
  • Cocoros NM, Klompas M. Ventilator-associated events and their prevention. Infect Dis Clin North Am. 2016 Dec;30(4):887–908. doi: 10.1016/j.idc.2016.07.002
  • Nseir S, Martin-Loeches I. In the name of ventilator-associated pneumonia prevention: lung microbiota blown away by colistin! Eur Respir J. 2015 Dec;46(6):1544–1547. doi: 10.1183/13993003.01361-2015
  • Erb CT, Patel B, Orr JE, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia. Ann Am Thorac Soc. 2016 Dec;13(12):2258–2260. doi: 10.1513/AnnalsATS.201608-641CME
  • Metersky ML, Kalil AC. Management of ventilator-associated pneumonia: guidelines. Clin Chest Med. 2018 Dec;39(4):797–808. doi: 10.1016/j.ccm.2018.08.002
  • Modi AR, Kovacs CS. Hospital-acquired and ventilator-associated pneumonia: diagnosis, management, and prevention. Cleve Clin J Med. [2020 Oct 1];87(10):633–639. doi: 10.3949/ccjm.87a.19117
  • Ferreira-Coimbra J, Ardanuy C, Diaz E, et al. Ventilator-associated pneumonia diagnosis: a prioritization exercise based on multi-criteria decision analysis. Eur J Clin Microbiol Infect Dis. 2020 Feb;39(2):281–286. doi: 10.1007/s10096-019-03720-x
  • de Steenhuijsen Piters WA, Huijskens EGW, Wyllie EG, et al. Dysbiosis of upper respiratory tract microbiota in elderly pneumonia patients. Isme J. 2016 Jan;10(1):97–108. doi: 10.1038/ismej.2015.99
  • Kalantar KL, Moazed F, Christenson SC, et al. Metagenomic comparison of tracheal aspirate and mini-bronchial alveolar lavage for assessment of respiratory microbiota. Am J Physiol Lung Cell Mol Physiol. [2019 Mar 1];316(3):L578–L584. doi: 10.1152/ajplung.00476.2018
  • Yang X, Wang X, Liang Z, et al. The use of 16S rDNA sequencing in species diversity analysis for sputum of patients with ventilator-associated pneumonia. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 May;26(5):294–299. doi: 10.3760/cma.j.issn.2095-4352.2014.05.002
  • Yao J, Guan S, Liu Z, et al. Changes in immune indicators and bacteriologic profile were associated with patients with ventilator-associated pneumonia. Medicine (Baltimore). 2020 Apr;99(16):e19716. doi: 10.1097/MD.0000000000019716
  • Kocacal Guler E, Turk G. Oral chlorhexidine against ventilator-associated pneumonia and microbial colonization in Intensive care patients. West J Nurs Res. 2019 Jun;41(6):901–919. doi: 10.1177/0193945918781531
  • Halm MA, Armola R. Effect of oral care on bacterial colonization and ventilator-associated pneumonia. Am J Crit Care. 2009 May;18(3):275–278. doi: 10.4037/ajcc2009842
  • Kelly BJ, Imai I, Bittinger K, et al. Composition and dynamics of the respiratory tract microbiome in intubated patients. Microbiome. [2016 Feb 11];4(1):7. doi: 10.1186/s40168-016-0151-8
  • Stearns JC, Davidson CJ, McKeon S, et al. Culture and molecular-based profiles show shifts in bacterial communities of the upper respiratory tract that occur with age. Isme J. 2015 May;9(5):1246–1259. doi: 10.1038/ismej.2014.250
  • Ren L, Wang Y, Zhong J, et al. Dynamics of the upper respiratory tract microbiota and its association with mortality in COVID-19. Am J Respir Crit Care Med. [2021 Dec 15];204(12):1379–1390. doi: 10.1164/rccm.202103-0814OC
  • de Carvalho Baptista IM, Martinho FC, Nascimento GG, et al. Colonization of oropharynx and lower respiratory tract in critical patients: risk of ventilator-associated pneumonia. Arch Oral Biol. 2018 Jan;85:64–69.
  • Bahrani-Mougeot FK, Paster BJ, Coleman S, et al. Molecular analysis of oral and respiratory bacterial species associated with ventilator-associated pneumonia. J Clin Microbiol. 2007 May;45(5):1588–1593. doi: 10.1128/JCM.01963-06
  • Soussan R, Schimpf C, Pilmis B, et al. Ventilator-associated pneumonia: the central role of transcolonization. J Crit Care. 2019 Apr;50:155–161.
  • Heo SM, Haase EM, Lesse AJ, et al. Genetic relationships between respiratory pathogens isolated from dental plaque and bronchoalveolar lavage fluid from patients in the intensive care unit undergoing mechanical ventilation. Clin Infect Dis. [2008 Dec 15];47(12):1562–1570. doi: 10.1086/593193
  • Huang D, Qi M, Hu Y, et al. The impact of Candida spp airway colonization on clinical outcomes in patients with ventilator-associated pneumonia: a systematic review and meta-analysis. Am J Infect Control. 2020 Jun;48(6):695–701. doi: 10.1016/j.ajic.2019.11.002
  • Tan X, Zhu S, Yan D, et al. Candida spp. airway colonization: a potential risk factor for Acinetobacter baumannii ventilator-associated pneumonia. Med Mycol. [2016 Aug 1];54(6):557–566. doi: 10.1093/mmy/myw009
  • Azoulay E, Timsit JF, Tafflet M, et al. Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia. Chest. 2006 Jan;129(1):110–117. doi: 10.1378/chest.129.1.110
  • Timsit JF, Schwebel C, Styfalova L, et al. Impact of bronchial colonization with Candida spp. On the risk of bacterial ventilator-associated pneumonia in the ICU: the FUNGIBACT prospective cohort study. Intensive care Med. 2019 Jun;45(6):834–843. doi: 10.1007/s00134-019-05622-0
  • Williamson DR, Albert M, Perreault MM, et al. The relationship between Candida species cultured from the respiratory tract and systemic inflammation in critically ill patients with ventilator-associated pneumonia. Can J Anaesth. 2011 Mar;58(3):275–284. doi: 10.1007/s12630-010-9439-5
  • Hamet M, Pavon A, Dalle F, et al. Candida spp. airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected ventilator-associated pneumonia. Intensive care Med. 2012 Aug;38(8):1272–1279. doi: 10.1007/s00134-012-2584-2
  • Delisle MS, Williamson DR, Albert M, et al. Impact of Candida species on clinical outcomes in patients with suspected ventilator-associated pneumonia. Can Respir J. 2011 May;18(3):131–136. doi: 10.1155/2011/827692
  • de Koff EM, Man WH, van Houten MA, et al. The respiratory microbiota during and following mechanical ventilation for respiratory infections in children. Eur Respir J. 2021 Apr;57(4):2002652. doi: 10.1183/13993003.02652-2020
  • Dickson RP, Huffnagle GB, Goldman WE. The lung microbiome: new principles for respiratory bacteriology in health and disease. PLOS Pathog. 2015 Jul;11(7):e1004923. doi: 10.1371/journal.ppat.1004923
  • Hong L, Chen Y, Ye L. Characteristics of the lung microbiota in lower respiratory tract infections with and without history of pneumonia. Bioengineered. 2021 Dec;12(2):10480–10490. doi: 10.1080/21655979.2021.1997563
  • Taylor SL, O’Farrell HE, Simpson JL, et al. The contribution of respiratory microbiome analysis to a treatable traits model of care. Respirology. 2019 Jan;24(1):19–28. doi: 10.1111/resp.13411
  • Mourani PM, Sontag MK, Williamson KM, et al. Temporal airway microbiome changes related to ventilator-associated pneumonia in children. Eur Respir J. 2021 Mar;57(3):2001829. doi: 10.1183/13993003.01829-2020
  • Zakharkina T, Martin-Loeches I, Matamoros S, et al. The dynamics of the pulmonary microbiome during mechanical ventilation in the intensive care unit and the association with occurrence of pneumonia. Thorax. 2017 Sep;72(9):803–810. doi: 10.1136/thoraxjnl-2016-209158
  • Dickson RP, Singer BH, Newstead MW, et al. Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome. Nat Microbiol. [2016 Jul 18];1(10):16113. doi: 10.1038/nmicrobiol.2016.113
  • Huebinger RM, Smith AD, Zhang Y, et al. Variations of the lung microbiome and immune response in mechanically ventilated surgical patients. PLoS One. 2018;13(10):e0205788. doi: 10.1371/journal.pone.0205788
  • Baek MG, Woo SJ, Kim NE, et al. Respiratory microbiome profiles differ by recent hospitalization and nursing home residence in patients on mechanical ventilation. J Transl Med. [2020 Dec 7];18(1):464. doi: 10.1186/s12967-020-02642-z
  • Alagna L, Mancabelli L, Magni F, et al. Changes in upper airways microbiota in ventilator-associated pneumonia. Intensive Care Med Exp. [2023 Mar 2];11(1):17. doi: 10.1186/s40635-023-00496-5
  • Otsuji K, Fukuda K, Ogawa M, et al. Dynamics of microbiota during mechanical ventilation in aspiration pneumonia. BMC Pulm Med. [2019 Dec 23];19(1):260. doi: 10.1186/s12890-019-1021-5
  • Kitsios GD, Fitch A, Manatakis DV, et al. Respiratory microbiome profiling for etiologic diagnosis of pneumonia in mechanically ventilated patients. Front Microbiol. 2018;9:1413. doi: 10.3389/fmicb.2018.01413
  • Cheema HA, Shahid A, Ayyan M, et al. Probiotics for the prevention of ventilator-associated pneumonia: An Updated systematic review and meta-analysis of Randomised Controlled trials. Nutrients. [2022 Apr 12];14(8):1600. doi: 10.3390/nu14081600
  • Huang YJ. The respiratory microbiome and innate immunity in asthma. Curr Opin Pulm Med. 2015 Jan;21(1):27–32. doi: 10.1097/MCP.0000000000000124
  • Boyton RJ, Reynolds CJ, Quigley KJ, et al. Immune mechanisms and the impact of the disrupted lung microbiome in chronic bacterial lung infection and bronchiectasis. Clin Exp Immunol. 2013 Feb;171(2):117–123. doi: 10.1111/cei.12003
  • Dickson RP, Erb-Downward JR, Huffnagle GB. The role of the bacterial microbiome in lung disease. Expert Rev Respir Med. 2013 Jun;7(3):245–257. doi: 10.1586/ers.13.24
  • Lambring CB, Siraj S, Patel K, et al. Impact of the microbiome on the immune System. Crit Rev Immunol. 2019;39(5):313–328. doi: 10.1615/CritRevImmunol.2019033233
  • Larsen JM, Steen-Jensen DB, Laursen JM, et al. Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota. PLoS One. 2012;7(2):e31976. doi: 10.1371/journal.pone.0031976
  • Siebert JC, Gorg C, Palmer B, et al. Visualizing microbiome-immune system interplay. Immunotherapy. 2019 Feb;11(2):63–67. doi: 10.2217/imt-2018-0138
  • Neish AS. Mucosal immunity and the microbiome. Ann Am Thorac Soc. 2014 Jan;11(Suppl 1):S28–32. doi: 10.1513/AnnalsATS.201306-161MG
  • Clarke TB, Bäumler AJ. Early innate immunity to bacterial infection in the lung is regulated systemically by the commensal microbiota via nod-like receptor ligands. Infect Immun. 2014 Nov;82(11):4596–4606. doi: 10.1128/IAI.02212-14
  • Gasaly N, de Vos P, Hermoso MA. Impact of bacterial metabolites on gut barrier function and host immunity: a focus on bacterial metabolism and its relevance for intestinal inflammation. Front Immunol. 2021;12:658354. doi: 10.3389/fimmu.2021.658354
  • Lopez LR, Ahn JH, Alves T, et al. Microenvironmental factors that shape bacterial metabolites in inflammatory bowel disease. Front Cell Infect Microbiol. 2022;12:934619. doi: 10.3389/fcimb.2022.934619
  • O’Dwyer DN, Dickson RP, Moore BB. The lung microbiome, immunity, and the pathogenesis of chronic lung disease. J Immunol. [2016 Jun 15];196(12):4839–4847. doi: 10.4049/jimmunol.1600279
  • Wang Z, Jenabian MA, Alexandrova Y, et al. Interplay between the lung microbiome, pulmonary immunity and viral reservoirs in people living with HIV under antiretroviral therapy. Viruses. [2022 Oct 29];14(11):2395. doi: 10.3390/v14112395
  • Dickson RP, Erb-Downward JR, Prescott HC, et al. Intraalveolar catecholamines and the human lung microbiome. Am J Respir Crit Care Med. [2015 Jul 15];192(2):257–259. doi: 10.1164/rccm.201502-0326LE
  • Caverly LJ, Huang YJ, Past SM. Present, and future research on the lung microbiome in inflammatory airway disease. Chest. 2019 Aug;156(2):376–382. doi: 10.1016/j.chest.2019.05.011
  • Li KJ, Chen ZL, Huang Y, et al. Dysbiosis of lower respiratory tract microbiome are associated with inflammation and microbial function variety. Respir Res. [2019 Dec 3];20(1):272. doi: 10.1186/s12931-019-1246-0
  • Mendez R, Banerjee S, Bhattacharya SK, et al. Lung inflammation and disease: a perspective on microbial homeostasis and metabolism. IUBMB Life. 2019 Feb;71(2):152–165. doi: 10.1002/iub.1969
  • Sands KM, Wilson MJ, Lewis MAO, et al. Respiratory pathogen colonization of dental plaque, the lower airways, and endotracheal tube biofilms during mechanical ventilation. J Crit Care. 2017 Feb;37:30–37.
  • Vandecandelaere I, Coenye T. Microbial composition and antibiotic resistance of biofilms recovered from endotracheal tubes of mechanically ventilated patients. Adv Exp Med Biol. 2015;830:137–155.
  • Hotterbeekx A, Xavier BB, Bielen K, et al. The endotracheal tube microbiome associated with Pseudomonas aeruginosa or Staphylococcus epidermidis. Sci Rep. [2016 Nov 4];6(1):36507. doi: 10.1038/srep36507
  • Flanagan JL, Brodie EL, Weng L, et al. Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa. J Clin Microbiol. 2007 Jun;45(6):1954–1962. doi: 10.1128/JCM.02187-06
  • Karacaer F, Hamed I, Ozogul F, et al. The function of probiotics on the treatment of ventilator-associated pneumonia (VAP): facts and gaps. J Med Microbiol. 2017 Sep;66(9):1275–1285. doi: 10.1099/jmm.0.000579
  • van Ruissen MCE, Bos LD, Dickson RP, et al. Manipulation of the microbiome in critical illness—probiotics as a preventive measure against ventilator-associated pneumonia. Intensive Care Med Exp. [2019 Jul 25];7(Suppl 1):37. doi: 10.1186/s40635-019-0238-1
  • Johnstone J, Meade M, Lauzier F, et al. Effect of probiotics on incident ventilator-associated pneumonia in critically ill patients: a randomized clinical trial. JAMA. [2021 Sep 21];326(11):1024–1033. doi: 10.1001/jama.2021.13355
  • Law N, Logan C, Yung G, et al. Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient. Infection. 2019 Aug;47(4):665–668. doi: 10.1007/s15010-019-01319-0
  • Chotirmall SH, Bogaert D, Chalmers JD, et al. Therapeutic targeting of the respiratory microbiome. Am J Respir Crit Care Med. [2022 Sep 1];206(5):535–544. doi: 10.1164/rccm.202112-2704PP
  • Huang WC, Wu MF, Huang CC, et al. Dynamics of the lung microbiome in intensive care patients with chronic obstructive pulmonary disease and community-acquired pneumonia. Sci Rep. [2020 Jul 6];10(1):11046. doi: 10.1038/s41598-020-68100-4
  • Carney SM, Clemente JC, Cox MJ, et al. Methods in lung microbiome research. Am J Respir Cell Mol Biol. 2020 Mar;62(3):283–299. doi: 10.1165/rcmb.2019-0273TR
  • Sulaiman I, Schuster S, Segal LN. Perspectives in lung microbiome research. Curr Opin Microbiol. 2020 Aug;56:24–29. doi: 10.1016/j.mib.2020.06.001
  • Tsitsiklis A, Osborne CM, Kamm J, et al. Lower respiratory tract infections in children requiring mechanical ventilation: a multicentre prospective surveillance study incorporating airway metagenomics. Lancet Microbe. 2022 Apr;3(4):e284–e293. doi: 10.1016/S2666-5247(21)00304-9
  • Langelier C, Kalantar KL, Moazed F, et al. Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults. Proc Natl Acad Sci U S A. [2018 Dec 26];115(52):E12353–E12362. doi: 10.1073/pnas.1809700115

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.